title: Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.
authors.forename: Subrata
authors.initials: S
authors.lastname: Mandal
authors.forename: Subijay
authors.initials: S
authors.lastname: Sinha
authors.forename: Zahir
authors.initials: Z
authors.lastname: Abbas
authors.forename: Pradeep
authors.initials: P
authors.lastname: Venkatesh
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000150:complications*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D005451:Fluorescein Angiography; D005584:Fovea Centralis / Q000098:blood supply*; D005654:Fundus Oculi; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D041623:Tomography, Optical Coherence
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab